Cordant, Inc. Ironwood Pharmaceuticals Inc Transaction History
Cordant, Inc.
- $190 Billion
- Q4 2024
Shares
4 transactions
Others Institutions Holding IRWD
# of Institutions
240Shares Held
161MCall Options Held
11.2MPut Options Held
19.2K-
Black Rock Inc. New York, NY22.9MShares$43.9 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA19.5MShares$37.5 Million0.0% of portfolio
-
Sarissa Capital Management LP Greenwich, CT16.4MShares$31.5 Million22.5% of portfolio
-
Pacer Advisors, Inc. Malvern, PA11.7MShares$22.5 Million0.13% of portfolio
-
Armistice Capital, LLC New York, NY9.47MShares$18.2 Million0.59% of portfolio
About IRONWOOD PHARMACEUTICALS INC
- Ticker IRWD
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 153,231,008
- Market Cap $294M
- Description
- Ironwood Pharmaceuticals, Inc., a healthcare company, focuses on the development and commercialization of gastrointestinal (GI) products. It markets linaclotide, a guanylate cyclase type-C agonist for the treatment of adults suffering from irritable bowel syndrome with constipation (IBS-C) or chronic idiopathic constipation (CIC) under the LINZE...